Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gribakina

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Eksperimental'Naia I Klinicheskaia Farmakologiia|June 18, 2013
[In vivo study of the pharmacokinetic interaction of afobazole and losartan (cytochrome CYP2C9 substrate)]O G Gribakina, G B Kolyvanov, A A Litvin, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|February 22, 2014
[In vivo evaluation of the metabolic ratio of CYP2C9 and CYP1A2 drug markers after administration of afobazole in comparison to standard inducers and inhibitors of cytochromes]Ia G Novitskaia, O G Gribakina, G B Kolyvanov, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|April 8, 2016
[EVALUATION OF THE PHARMACOKINETIC INTERACTION OF AFOBAZOLE WITH CYP2C9 ENZYME DRUG SUBSTRATE OF CYTOCHROME P450]O G Gribakina, G B Kolyvanov, A A Litvin, et al.
Bulletin of Experimental Biology and Medicine|October 25, 2018
Metabolism of a Novel Anxiolytic GML-1 in RatsA A Novitskii, P O Bochkov, R V Shevchenko, et al.
Bulletin of Experimental Biology and Medicine|October 19, 2019
Comparative Preclinical Pharmacokinetics and Bioavailability of Antidepressant GSB-106 Tablet FormG B Kolyvanov, V P Zherdev, O G Gribakina, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Eksperimental'Naia I Klinicheskaia Farmakologiia|June 18, 2013
[In vivo study of the pharmacokinetic interaction of afobazole and losartan (cytochrome CYP2C9 substrate)]O G Gribakina, G B Kolyvanov, A A Litvin, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|February 22, 2014
[In vivo evaluation of the metabolic ratio of CYP2C9 and CYP1A2 drug markers after administration of afobazole in comparison to standard inducers and inhibitors of cytochromes]Ia G Novitskaia, O G Gribakina, G B Kolyvanov, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|April 8, 2016
[EVALUATION OF THE PHARMACOKINETIC INTERACTION OF AFOBAZOLE WITH CYP2C9 ENZYME DRUG SUBSTRATE OF CYTOCHROME P450]O G Gribakina, G B Kolyvanov, A A Litvin, et al.
Bulletin of Experimental Biology and Medicine|October 25, 2018
Metabolism of a Novel Anxiolytic GML-1 in RatsA A Novitskii, P O Bochkov, R V Shevchenko, et al.
Bulletin of Experimental Biology and Medicine|October 19, 2019
Comparative Preclinical Pharmacokinetics and Bioavailability of Antidepressant GSB-106 Tablet FormG B Kolyvanov, V P Zherdev, O G Gribakina, et al.
Pageof 1